Hornstein Mark D
Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA
Reprod Sci. 2016 Dec;23(12):1630-1633. doi: 10.1177/1933719116667227. Epub 2016 Sep 13.
This review provides a brief look at the state of the assisted reproductive technologies (ARTs) in the United States in 2016. In 2013, the most recent year for which data are available through the Society for Assisted Reproductive Technology (SART) of the American Society for Reproductive Medicine (ASRM) and the Centers for Disease Control and Prevention (CDC), there were 190 773 total cycles of ART. Live births ranged from 40.1% per cycle initiated in women younger than 35 years to 4.5% live births per cycle initiated in women older than 42 years. US clinics must report their outcomes to the CDC. Society for Assisted Reproductive Technology clinics must report through the SART, which maintains rigorous quality assurance and validation programs. Society for Assisted Reproductive Technology member clinics must abide by minimum standards set by the SART and the ASRM, which include educational and other requirements for professionals participating in in vitro fertilization programs as well as standards for the laboratories. Assisted reproductive technology in the United States is a highly regulated field on a voluntary basis with excellent clinical results.
本综述简要介绍了2016年美国辅助生殖技术（ART）的状况。2013年是可通过美国生殖医学学会（ASRM）的辅助生殖技术协会（SART）和疾病控制与预防中心（CDC）获取数据的最近一年，ART总周期数为190773个。活产率从35岁以下女性每启动一个周期的40.1%到42岁以上女性每启动一个周期的4.5%不等。美国的诊所必须向CDC报告其治疗结果。辅助生殖技术协会的诊所必须通过SART进行报告，SART设有严格的质量保证和验证程序。辅助生殖技术协会的成员诊所必须遵守SART和ASRM制定的最低标准，这些标准包括对参与体外受精项目的专业人员的教育及其他要求，以及实验室标准。美国的辅助生殖技术是一个在自愿基础上受到高度监管且临床效果良好的领域。
